As of 2025-09-16, the Relative Valuation of Neurocrine Biosciences Inc (NBIX) is 67.11 USD. This relative valuation is based on P/E multiples. With the latest stock price at 140.44 USD, the upside of Neurocrine Biosciences Inc based on Relative Valuation is -52.2%.
The range of the Relative Valuation is 51.76 - 87.70 USD.
| Range | Selected | |
| Trailing P/E multiples | 14.7x - 17.9x | 16.4x |
| Forward P/E multiples | 16.6x - 21.7x | 18.9x |
| Fair Price | 51.76 - 87.70 | 67.11 |
| Upside | -63.1% - -37.6% | -52.2% |
| Date | P/E |
| 2025-09-15 | 39.99 |
| 2025-09-12 | 40.40 |
| 2025-09-11 | 40.89 |
| 2025-09-10 | 40.22 |
| 2025-09-09 | 41.05 |
| 2025-09-08 | 40.95 |
| 2025-09-05 | 41.03 |
| 2025-09-04 | 39.98 |
| 2025-09-03 | 38.76 |
| 2025-09-02 | 40.41 |
| 2025-08-29 | 39.75 |
| 2025-08-28 | 39.56 |
| 2025-08-27 | 39.33 |
| 2025-08-26 | 38.97 |
| 2025-08-25 | 38.15 |
| 2025-08-22 | 38.56 |
| 2025-08-21 | 38.52 |
| 2025-08-20 | 37.94 |
| 2025-08-19 | 37.82 |
| 2025-08-18 | 37.91 |
| 2025-08-15 | 37.84 |
| 2025-08-14 | 37.39 |
| 2025-08-13 | 37.48 |
| 2025-08-12 | 36.70 |
| 2025-08-11 | 35.30 |
| 2025-08-08 | 35.60 |
| 2025-08-07 | 35.77 |
| 2025-08-06 | 36.57 |
| 2025-08-05 | 36.56 |
| 2025-08-04 | 36.46 |
| 2025-08-01 | 36.71 |
| 2025-07-31 | 36.51 |
| 2025-07-30 | 38.94 |
| 2025-07-29 | 38.21 |
| 2025-07-28 | 38.07 |
| 2025-07-25 | 37.63 |
| 2025-07-24 | 37.49 |
| 2025-07-23 | 38.06 |
| 2025-07-22 | 37.80 |
| 2025-07-21 | 37.54 |
| 2025-07-18 | 37.59 |
| 2025-07-17 | 38.19 |
| 2025-07-16 | 38.01 |
| 2025-07-15 | 37.37 |
| 2025-07-14 | 38.48 |
| 2025-07-11 | 38.00 |
| 2025-07-10 | 38.42 |
| 2025-07-09 | 38.02 |
| 2025-07-08 | 36.66 |
| 2025-07-07 | 36.41 |